iv semaglutide Ozempic® (semaglutide) GLP-1 RA for Type 2 Diabetes A Comprehensive Guide to Semaglutide

Download or preview the resources below Step 3: Determination If the PA is approved, your patients insurance covers Wegovy

The Bottom Line (Plain English) Weeks 12: appetite changes, little scale movement Weeks 36: weight loss often begins Months 36: meaningful, sustained loss for many Semaglutide: slower start, steady progress Tirzepatide: faster early loss for some, same long-term rules apply GLP-1 rewards patience not urgency

The choice between semaglutide vs tirzepatide is about choosing the option that works best for you with negligible side effects

Download or preview the resources below Steps to help you with determining access to Wegovy Step 1: Conduct a benefits investigation to determine a patients coverage and PA requirements For commercially insured patients, consider using Novo Nordisks electronic benefits verification on NovoCare